SEARCH RESULTS for MILLENNIUM PHARMACEUTICALS, INC.

Recent Patent Assignments Patent Assignments - (Total found: 73)

Patent(s) Assignor(s) Orig. Assignee(s) Assignee(s) Reel/Frame

(X0) 10495041: USE OF INHIBITORS OF I$G(K)B KINEASE FOR THE TREATMENT OF CANCER

(A1) 20050049265: USE OF INHIBITORS OF I$G(K)B KINEASE FOR THE TREATMENT OF CANCER

(B2) 9248124: USE OF INHIBITORS OF I$G(K)B KINEASE FOR THE TREATMENT OF CANCER

ADAMS, JULIAN

N/A

MILLENNIUM PHARMACEUTICALS, INC.

15221/961

(X0) 08822445: COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF CHEDIAK-HIGASHI SYNDROME

(B1) 5952223: COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF CHEDIAK-HIGASHI SYNDROME

MOORE, KAREN J.

N/A

MILLENNIUM PHARMACEUTICALS, INC.

8678/599

(X0) 08826248: COMPOSITIONS AND METHODS FOR THE TREATMENT AND DIAGNOSIS OF CARDIOVASCULAR DISEASE

(B1) 6759210: COMPOSITIONS AND METHODS FOR THE TREATMENT AND DIAGNOSIS OF CARDIOVASCULAR DISEASE

FALB, DEAN A.

N/A

MILLENNIUM PHARMACEUTICALS, INC.

8716/704

(X0) 08825486: COMPOSITIONS AND METHODS FOR THE TREATMENT AND DIAGNOSIS OF CARDIOVASCULAR DISEASE

(A1) 20020016303: COMPOSITIONS AND METHODS FOR THE TREATMENT AND DIAGNOSIS OF CARDIOVASCULAR DISEASE

(B2) 6534641: COMPOSITIONS AND METHODS FOR THE TREATMENT AND DIAGNOSIS OF CARDIOVASCULAR DISEASE

FALB, DEAN A.

N/A

MILLENNIUM PHARMACEUTICALS, INC.

8716/711

(X0) 08202990: METHODS FOR IDENTIFYING INHIBITORS OF FUNGAL PATHOGENICITY

(B1) 5614377: METHODS FOR IDENTIFYING INHIBITORS OF FUNGAL PATHOGENICITY

CHEMGENICS PHARMACEUTICALS, INC.

N/A

MILLENNIUM PHARMACEUTICALS, INC.

8761/423

(X0) 08202990: METHODS FOR IDENTIFYING INHIBITORS OF FUNGAL PATHOGENICITY

(B1) 5614377: METHODS FOR IDENTIFYING INHIBITORS OF FUNGAL PATHOGENICITY

CHEMGENICS PHARMACEUTICALS INC.

N/A

MILLENNIUM PHARMACEUTICALS, INC.

8761/637

(X0) 08202990: METHODS FOR IDENTIFYING INHIBITORS OF FUNGAL PATHOGENICITY

(B1) 5614377: METHODS FOR IDENTIFYING INHIBITORS OF FUNGAL PATHOGENICITY

CHEMGENICS PHARMACEUTICALS, INC.

N/A

MILLENNIUM PHARMACEUTICALS, INC.

8761/640

(X0) 08551420: ANTIFUNGAL AGENTS DERIVED FROM ASPERGILLUS FUMIGATUS

(B1) 5837726: ANTIFUNGAL AGENTS DERIVED FROM ASPERGILLUS FUMIGATUS

CHEMGENICS PHARMACEUTICALS, INC.

N/A

MILLENNIUM PHARMACEUTICALS, INC.

8762/194

(X0) 08925743: COMPOSITIONS AND METHODS FOR THE TREATMENT AND DIAGNOSIS OF CARDIOVASCULAR DISEASE USING RCHD534 AS A TARGET

(B1) 6054558: COMPOSITIONS AND METHODS FOR THE TREATMENT AND DIAGNOSIS OF CARDIOVASCULAR DISEASE USING RCHD534 AS A TARGET

FALB, DEAN A.

N/A

MILLENNIUM PHARMACEUTICALS, INC.

8764/138

(X0) 08833226: ISOLATED DNA ENCODING A NOVEL HUMAN G-PROTEIN COUPLED RECEPTOR

(B1) 5891720: ISOLATED DNA ENCODING A NOVEL HUMAN G-PROTEIN COUPLED RECEPTOR

MOORE, KAREN

NAGLE, DEBORAH LYNN

WOOLF, ELIZABETH A.

N/A

MILLENNIUM PHARMACEUTICALS, INC.

8782/243

(X0) 09456455: 14273 RECEPTOR, A NOVEL G-PROTEIN COUPLED RECEPTOR

(B1) 6448005: 14273 RECEPTOR, A NOVEL G-PROTEIN COUPLED RECEPTOR

GLUCKSMANN, MARIA ALEXANDRA

TSAI, FONG-YING

N/A

MILLENNIUM PHARMACEUTICALS, INC.

10687/816

(X0) 09420190: METHODS FOR USING 22045, A HUMAN CYCLIC NUCLEOTIDE PHOSPHODIESTERASE

(A1) 20020081633: METHODS FOR USING 22045, A HUMAN CYCLIC NUCLEOTIDE PHOSPHODIESTERASE

(B2) 6673564: METHODS FOR USING 22045, A HUMAN CYCLIC NUCLEOTIDE PHOSPHODIESTERASE

KAPELLER-LIBERMANN, ROSANA

HUNTER, JOHN JOSEPH

WILLIAMSON, MARK

N/A

MILLENNIUM PHARMACEUTICALS, INC.

10695/644

(X0) 09443795: 2786, A NOVEL HUMAN AMINOPEPTIDASE

(B1) 6383780: 2786, A NOVEL HUMAN AMINOPEPTIDASE

KAPELLER-LIBERMANN, ROSANA

WHITE, DAVID

MACBETH, KYLE J.

N/A

MILLENNIUM PHARMACEUTICALS, INC.

10716/339

(X0) 09448076: METHODS OF USE OF A NOVEL LYSYL OXIDASE-RELATED PROTEIN

(B1) 6300092: METHODS OF USE OF A NOVEL LYSYL OXIDASE-RELATED PROTEIN

KHODADOUST, MEHRAN M.

MACBETH, KYLE J.

N/A

MILLENNIUM PHARMACEUTICALS, INC.

10745/849

(X0) 09134674: SYNTHESIS OF CLASTO-LACTACYSTIN BETA-LACTONE AND ANALOGS THEREOF

(B1) 6133308: SYNTHESIS OF CLASTO-LACTACYSTIN BETA-LACTONE AND ANALOGS THEREOF

LEUKOSITE, INC.

N/A

MILLENNIUM PHARMACEUTICALS, INC.

10768/787

(X0) 09333159: NUCLEIC ACIDS CORRESPONDING TO TANGO 294 A GENE ENCODING A LIPASE - LIKE PROTEIN

(B1) 7033780: NUCLEIC ACIDS CORRESPONDING TO TANGO 294 A GENE ENCODING A LIPASE - LIKE PROTEIN

MILLENNIUM BIOTHERAPEUTICS, INC.

N/A

MILLENNIUM PHARMACEUTICALS, INC.

10772/419

(X0) 09458457: NOVEL CARK PROTEIN AND NUCLEIC ACID MOLECULES AND USES THEREFOR

(B1) 6500654: NOVEL CARK PROTEIN AND NUCLEIC ACID MOLECULES AND USES THEREFOR

RAJU, JEYASEELAN

N/A

MILLENNIUM PHARMACEUTICALS, INC.

10773/182

(X0) 09449437: METHODS FOR DETECTING AND/OR IDENTIFYING AGENTS WHICH BIND AND/OR MODULATE FUNCTION OF "BONZO" CHEMOKINE RECEPTOR

(B1) 6319675: METHODS FOR DETECTING AND/OR IDENTIFYING AGENTS WHICH BIND AND/OR MODULATE FUNCTION OF "BONZO" CHEMOKINE RECEPTOR

BRISKIN, MICHAEL J.

MURPHY, KRISTINE E.

WILBANKS, ALYSON M.

WU, LIJUN

N/A

MILLENNIUM PHARMACEUTICALS, INC.

10797/369

(X0) 09507146: BIOTINYLATED-CHEMOKINE ANTIBODY COMPLEXES

(B1) 6869606: BIOTINYLATED-CHEMOKINE ANTIBODY COMPLEXES

NEWMAN, WALTER

PICARELLA, DOMINIC

SOLER, DULCE

N/A

MILLENNIUM PHARMACEUTICALS, INC.

10818/97

(X0) 08890979: DIAGNOSTIC ASSAYS AND KITS FOR BODY MASS DISORDERS ASSOCIATED WITH A POLYMORPHISM IN AN INTRON SEQUENCE OF THE SR-BI GENE

(B1) 6030778: DIAGNOSTIC ASSAYS AND KITS FOR BODY MASS DISORDERS ASSOCIATED WITH A POLYMORPHISM IN AN INTRON SEQUENCE OF THE SR-BI GENE

ACTON, SUSAN L.

N/A

MILLENNIUM PHARMACEUTICALS, INC.

10832/712

(X0) 08635552: MAMMALIAN HYALURONAN SYNTHASES, NUCLEIC ACIDS AND USES THEREOF

(B1) 6423514: MAMMALIAN HYALURONAN SYNTHASES, NUCLEIC ACIDS AND USES THEREOF

LEUKOSITE, INC.

N/A

MILLENNIUM PHARMACEUTICALS, INC.

10838/644

(X0) 09266464: ANTI-GPR-9-6 ANTIBODIES AND METHODS OF IDENTIFYING AGENTS WHICH MODULATE GPR-9-6 FUNCTION

(B1) 6329159: ANTI-GPR-9-6 ANTIBODIES AND METHODS OF IDENTIFYING AGENTS WHICH MODULATE GPR-9-6 FUNCTION

LEUKOSITE, INC.

N/A

MILLENNIUM PHARMACEUTICALS, INC.

10839/832

(X0) 09359193: ANTI-CCR2 ANTIBODIES AND METHODS OF USE THEREFOR

(B1) 6352832: ANTI-CCR2 ANTIBODIES AND METHODS OF USE THEREFOR

LEUKOSITE, INC.

N/A

MILLENNIUM PHARMACEUTICALS, INC.

10839/836

(X0) 09464039: 21612, NOVEL HUMAN ALCOHOL DEHYDROGENASES

(B1) 7094565: 21612, NOVEL HUMAN ALCOHOL DEHYDROGENASES

MEYERS, RACHEL

N/A

MILLENNIUM PHARMACEUTICALS, INC.

10840/266

(X0) 14788675: HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF SUMO ACTIVATING ENZYME

(A1) 20170002032: HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF SUMO ACTIVATING ENZYME

DUFFEY, MATTHEW O.

ENGLAND, DYLAN B.

FREEZE, BRIAN SCOTT

HU, ZHIGEN

LANGSTON, STEVEN P.

MCINTYRE, CHARLES J.

MIZUTANI, HIROTAKE

XU, HE

MILLENNIUM PHARMACEUTICALS, INC.

38599/450

(X0) 15215000: FORMULATION FOR ANTI-ALPHA4BETA7 ANTIBODY

(A1) 20170002078: FORMULATION FOR ANTI-ALPHA4BETA7 ANTIBODY

FOX, IRVING H.

SCHOLZ, CATHERINE

MILLENNIUM PHARMACEUTICALS, INC.

39841/506

(X0) 15215012: FORMULATION FOR ANTI-ALPHA4BETA7 ANTIBODY

(A1) 20160340432: FORMULATION FOR ANTI-ALPHA4BETA7 ANTIBODY

FOX, IRVING H.

SCHOLZ, CATHERINE

MILLENNIUM PHARMACEUTICALS, INC.

41398/933

(X0) 14328256: METHODS OF TREATMENT USING PYRIDINONYL PDK1 INHIBITORS

(A1) 20150018351: METHODS OF TREATMENT USING PYRIDINONYL PDK1 INHIBITORS

BIOGEN IDEC MA INC.

MILLENNIUM PHARMACEUTICALS, INC.

41347/885

(X0) 15305340: ANTI-PSYK ANTIBODY MOLECULES AND USE OF SAME FOR SYK-TARGETED THERAPY

(A1) 20170037151: ANTI-PSYK ANTIBODY MOLECULES AND USE OF SAME FOR SYK-TARGETED THERAPY

BRAKE, RACHAEL L.

BURKHARDT, ANNE L.

HE MCDOUGALL, HELEN D.

KANNAN, KARUPPIAH

THEISEN, MATTHEW

TIRRELL, STEPHEN M.

MILLENNIUM PHARMACEUTICALS, INC.

41245/752

(X0) 14896013: METHODS OF TREATMENT OF CANCER

(A1) 20170035917: METHODS OF TREATMENT OF CANCER

BRADLEY, DANIEL P.

ROBERTSON, ROBBIE J.

MILLENNIUM PHARMACEUTICALS, INC.

40937/130

(X0) 14444007: SUBSTITUTED 1,3-THIAZOLES AS SYNTHETIC INTERMEDIATES FOR PREPARATION OF RAF KINASE INHIBITORS

(A1) 20150080568: SUBSTITUTED 1,3-THIAZOLES AS SYNTHETIC INTERMEDIATES FOR PREPARATION OF RAF KINASE INHIBITORS

(B2) 9556177: SUBSTITUTED 1,3-THIAZOLES AS SYNTHETIC INTERMEDIATES FOR PREPARATION OF RAF KINASE INHIBITORS

BIOGEN IDEC MA INC.

N/A

MILLENNIUM PHARMACEUTICALS, INC.

36175/639

(X0) 14810225: COMPOUNDS AND METHODS FOR INHIBITING MITOTIC PROGRESSION

(A1) 20160185782: COMPOUNDS AND METHODS FOR INHIBITING MITOTIC PROGRESSION

CLAIBORNE, CHRISTOPHER F.

PAYNE, LLOYD J.

BOYCE, RICHARD J.

SELLS, TODD B.

STROUD, STEPHEN G.

TRAVERS, STUART

VOS, TRICIA J.

WEATHERHEAD, GABRIEL S.

MILLENNIUM PHARMACEUTICALS, INC.

40996/792

(X0) 13499835: HETEROCYCLIC COMPOUNDS USEFUL AS PDK1 INHIBITORS

(A1) 20120208819: HETEROCYCLIC COMPOUNDS USEFUL AS PDK1 INHIBITORS

(B2) 9546165: HETEROCYCLIC COMPOUNDS USEFUL AS PDK1 INHIBITORS

BIOGEN IDEC MA INC.

N/A

MILLENNIUM PHARMACEUTICALS, INC.

28013/222

7576206: PROTEASOME INHIBITORS AND METHODS OF USING THE SAME

7915236: PROTEASOME INHIBITORS AND METHODS OF USING THE SAME

8058262: PROTEASOME INHIBITORS AND METHODS OF USING THE SAME

8546608: Proteasome Inhibitors and Methods of Using the Same

TEVA PHARMACEUTICALS

N/A

N/A

N/A

N/A

MILLENNIUM PHARMACEUTICALS, INC.

37267/401

(X0) 13207696: HETEROARYLS AND USES THEREOF

(A1) 20120178723: HETEROARYLS AND USES THEREOF

(B2) 8796271: HETEROARYLS AND USES THEREOF

TAKEDA PHARMACEUTICAL COMPANY LIMITED

N/A

MILLENNIUM PHARMACEUTICALS, INC.

31079/582

(X0) 12657853: Heteroaryls and uses thereof

(A1) 20110003806: Heteroaryls and uses thereof

(B2) 9139589: Heteroaryls and uses thereof

TAKEDA PHARMACEUTICAL COMPANY LIMITED

N/A

MILLENNIUM PHARMACEUTICALS, INC.

31080/239

(X0) 13206671: HETEROARYLS AND USES THEREOF

(A1) 20120142732: HETEROARYLS AND USES THEREOF

(B2) 8859768: HETEROARYLS AND USES THEREOF

TAKEDA PHARMACEUTICAL COMPANY LIMITED

N/A

MILLENNIUM PHARMACEUTICALS, INC.

31080/929

(X0) 13207753: HETEROARYLS AND USES THEREOF

(A1) 20120172345: HETEROARYLS AND USES THEREOF

(B2) 8796268: HETEROARYLS AND USES THEREOF

TAKEDA PHARMACEUTICAL COMPANY LIMITED

N/A

MILLENNIUM PHARMACEUTICALS, INC.

31081/538

(X0) 12657854: Thiazole derivatives

(A1) 20110003807: Thiazole derivatives

(B2) 9090601: Thiazole derivatives

TAKEDA PHARMACEUTICAL COMPANY LIMITED

N/A

MILLENNIUM PHARMACEUTICALS, INC.

31117/306

(X0) 13151701: CCR1 ANTAGONISTS AND METHODS OF USE THEREFOR

(A1) 20110230516: CCR1 ANTAGONISTS AND METHODS OF USE THEREFOR

(B2) 8394817: CCR1 ANTAGONISTS AND METHODS OF USE THEREFOR

CARSON, KENNETH G.

HARRIMAN, GERALDINE C.B.

GHOSH, SHOMIR

N/A

MILLENNIUM PHARMACEUTICALS, INC.

31140/31

(X0) 12657853: Heteroaryls and uses thereof

(A1) 20110003806: Heteroaryls and uses thereof

(B2) 9139589: Heteroaryls and uses thereof

LANGSTON, STEVEN P.

MIZUTANI, HIROTAKE

VYSKOCIL, STEPAN

N/A

MILLENNIUM PHARMACEUTICALS, INC.

31143/102

(X0) 12970531: METHODS OF PREPARING FACTOR XA INHIBITORS AND SALTS THEREOF

(A1) 20110152530: METHODS OF PREPARING FACTOR XA INHIBITORS AND SALTS THEREOF

(B2) 8742120: METHODS OF PREPARING FACTOR XA INHIBITORS AND SALTS THEREOF

PANDEY, ANJALI

PANDYA, URVISH

N/A

MILLENNIUM PHARMACEUTICALS, INC.

25913/815

(X0) 12970818: CRYSTALLINE FORMS OF A FACTOR XA INHIBITOR

(A1) 20110160250: CRYSTALLINE FORMS OF A FACTOR XA INHIBITOR

PANDEY, ANJALI

WANG, JUAN

LAMBING, JOSEPH

MILLENNIUM PHARMACEUTICALS, INC.

25936/482

(X0) 12436271: CHEMOKINE RECEPTOR ANTAGONISTS AND METHODS OF USE THEREFOR

(A1) 20090281081: CHEMOKINE RECEPTOR ANTAGONISTS AND METHODS OF USE THEREFOR

(B2) 8058287: CHEMOKINE RECEPTOR ANTAGONISTS AND METHODS OF USE THEREFOR

LULY, JAY R.

HARRIMAN, GERALDINE C.B.

CARSON, KENNETH G.

GHOSH, SHOMIR

ELDER, AMY M.

MATTIA, KAREN M.

NAKASATO, YOSHISUKE

OHSHIMA, ETSUO

N/A

MILLENNIUM PHARMACEUTICALS, INC.

25981/427

(X0) 11904098: EGF-LIKE NUCLEIC ACIDS AND POLYPEPTIDES AND USES THEREOF

(A1) 20090117583: EGF-LIKE NUCLEIC ACIDS AND POLYPEPTIDES AND USES THEREOF

(B2) 7803564: EGF-LIKE NUCLEIC ACIDS AND POLYPEPTIDES AND USES THEREOF

BUSFIELD, SAMANTHA J.

GEARING, DAVID P.

N/A

MILLENNIUM PHARMACEUTICALS, INC.

21114/53

(X0) 11594280: NOVEL PHARMACEUTICAL SALTS AND POLYMORPHS OF A FACTOR XA INHIBITOR

(A1) 20070112039: NOVEL PHARMACEUTICAL SALTS AND POLYMORPHS OF A FACTOR XA INHIBITOR

(B2) 7598276: NOVEL PHARMACEUTICAL SALTS AND POLYMORPHS OF A FACTOR XA INHIBITOR

KANTER, JAMES P.

GRANT, CRAIG

LANGLANDS, GRAEME

N/A

MILLENNIUM PHARMACEUTICALS, INC.

18844/310

(X0) 11599151: Humanized immunoglobulin reactive with alpha4beta7 integrin

(A1) 20070122404: Humanized immunoglobulin reactive with alpha4beta7 integrin

O'KEEFE, THERESA L

MILLENNIUM PHARMACEUTICALS, INC.

18850/649

(X0) 11635725: Isolation of ansamitocins

(A1) 20070135629: Isolation of ansamitocins

PATIL, ASHOK D.

MILLENNIUM PHARMACEUTICALS, INC.

18892/80

(X0) 11636609: BICYCLIC COMPOUNDS WITH KINASE INHIBITORY ACTIVITY

(A1) 20070149533: BICYCLIC COMPOUNDS WITH KINASE INHIBITORY ACTIVITY

(B2) 8110687: BICYCLIC COMPOUNDS WITH KINASE INHIBITORY ACTIVITY

CALDERWOOD, EMILY F.

DUFFEY, MATTHEW

GOULD, ALEXANDRA E.

GREENSPAN, PAUL D.

KULKARNI, BHEEMASHANKAR

LAMARCHE, MATTHEW J.

ROWLAND, ROBYN SCOTT

TREGAY, MING

VOS, TRICIA J.

N/A

MILLENNIUM PHARMACEUTICALS, INC.

18964/452

(X0) 10966846: CARD-4 molecules and uses thereof

(A1) 20050287612: CARD-4 molecules and uses thereof

INSTITUT PASTEUR

MILLENNIUM PHARMACEUTICALS, INC.

16847/837